Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta Induced Protein (TGFBIp) offers a new avenue for treatment of TGFBI- corneal dystrophy

Publication date: Available online 22 May 2020Source: Journal of Advanced ResearchAuthor(s): Venkatraman Anandalakshmi, Minh-Dao Duong-Thi, Konstantin Pervushin, Sten Ohlson, Jodhbir Singh Mehta
Source: Journal of Advanced Research - Category: Research Source Type: research